• Candel Therapeutics (NASDAQ:CADL) Posts Quarterly Earnings Results, Misses Estimates By $0.17 EPS

    Source: Buzz FX / 14 Mar 2025 17:16:16   America/New_York


    Candel Therapeutics (NASDAQ:CADL) Posts Quarterly Earnings Results, Misses Estimates By $0.17 EPS Written by MarketBeat March 14, 2025 Share Link copied to clipboard. Remove Ads Candel Therapeutics ( NASDAQ:CADL - Get Free Report ) issued i
    Read more...
Share on,